Disease block
K70-K77 – Krankheiten der Leber
- Chapter XI: Krankheiten des Verdauungssystems
15Decisions
15Patient groups
Added benefit by patient group
- Minor3
- Non-quantifiable3
- Deemed proven8
- Not proven1
Diseases in this disease block
- K74 Fibrose und Zirrhose der Leber 4 decisions
- K75 Sonstige entzündliche Leberkrankheiten 10 decisions
- K76 Sonstige Krankheiten der Leber 1 decision
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-09-03UpliznaInebilizumabNon-quantifiable
- 2026-07-16XeravaEravacyclinDeemed proven
- 2026-03-05RezdiffraResmetiromNot proven
- 2025-09-04Lyvdelzi (previously Seladelpar Gilead)SeladelparMinor
- 2025-05-15ZaviceftaCeftazidim/AvibactamDeemed proven
- 2025-04-17VaboremMeropenem/VaborbactamDeemed proven
- 2025-04-03IqirvoElafibranorMinor
- 2025-02-20EmblaveoAztreonam/AvibactamDeemed proven
- 2025-02-06LivmarliMaralixibatNon-quantifiable
- 2023-02-02ZerbaxaCeftolozan/TazobactamDeemed proven
- 2023-01-19XeravaEravacyclinDeemed proven
- 2022-11-03ZaviceftaCeftazidim/AvibactamDeemed proven
- 2022-11-03ZerbaxaCeftolozan/TazobactamDeemed proven
- 2022-03-03BylvayOdevixibatMinor
- 2014-11-06OrphacolCholsäureNon-quantifiable
Data status: 2026-10-29